Mark Cuban’s Cost Plus Drugs Company will import a drug used to treat syphilis amid a national shortage | MSN
Excerpt from MSN: “Mark Cuban’s Cost Plus Drugs Company has received approval from the U.S. Food and Drug Administration to import a drug used to treat syphilis amid a national shortage. Dallas-based Cost Plus Drugs is coordinating with the FDA to temporarily import a form of penicillin made by Portugal-based Laboratorios Atral S.A., according to a letter on the FDA’s website.” Read more.
Purdue Pharma bankruptcy deal ruling is taking courts by storm | Bloomberg Law
Excerpt from Bloomberg Law: “The US Supreme Court’s decision striking down Purdue Pharma’s bankruptcy settlement is already being craftily applied by lawyers looking to push its authority as far as possible and carefully parsed by judges interpreting the extent of its impact.” Read more.
Torrid market for copycat weight loss drugs could be short-lived | NPR
Excerpt from NPR: “Off-brand weight loss drugs containing the same active ingredients as Wegovy and Zepbound seem to be everywhere. Ads for the much cheaper alternatives are popping up on Instagram, in the subway and on TV. But there are rules about when these copycats of brand-name drugs are allowed — and things could change once the original versions made by Novo Nordisk and Eli Lilly are no longer in short supply. The companies are ramping up their manufacturing now to meet skyrocketing demand.” Read more.
Sorry, the comment form is closed at this time.